New care pathway aims to tame agitation in Alzheimer's without overmedicating
NCT ID NCT03672201
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a structured care pathway for treating agitation and aggression in people with Alzheimer's disease. The pathway combines personalized activities with medication guidelines to reduce symptoms and avoid using too many drugs. Researchers will compare this approach to usual care in 187 patients living in hospitals or long-term care facilities.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Integrated Care Pathway (ICP) combining behavioral activities and medication guidelines
What this could lead to
If successful, this could provide a standardized, effective approach to manage agitation and aggression in Alzheimer's, reducing reliance on multiple medications.
What could go wrong
This is a relatively small study (187 participants) and the intervention is complex, making it hard to isolate which part works. Results may not apply to all care settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Addiction and Mental Health
Toronto, Ontario, M6J 1H4, Canada
-
Douglas Hospital Research Centre
Montreal, Quebec, H4H 1R3, Canada
-
LAWSON Health Research Institute
London, Ontario, N6C 2R5, Canada
-
Ontario Shores Centre for Mental Health Sciences
Whitby, Ontario, L1N 5S9, Canada
-
Providence Care
Kingston, Ontario, K7L 4X3, Canada
-
University of Calgary
Calgary, Alberta, T2N 1N4, Canada